术中多模态技术的应用可改善成人胶质母细胞瘤的预后:一项单中心观察性研究
该单中心观察性研究基于华山胶质瘤登记数据,纳入912例成人胶质母细胞瘤患者,按术中多模态技术使用数量分为非多模态组(不足2种)和多模态组(2种及以上),比较两组预后并按诊断年份(2010-2014年或2015-2019年)分层。结果显示多模态组总生存期长于非多模态组(21.0个月 vs 16.0个月,P<0.001),且2015-2019年组较2010-2014年组总生存期延长(22.0个月 vs 16.0个月,P<0.001)。
要点
- 多模态组总生存期21.0个月,长于非多模态组的16.0个月(P<0.001)。
- 2015-2019年组总生存期22.0个月,长于2010-2014年组的16.0个月(P<0.001)。
- 多模态技术更常用于2015-2019年组的手术中。
核心结论
- 术中多模态技术的应用改善了成人胶质母细胞瘤的切除程度并提高了生存期。
研究设计与样本
- 单中心观察性研究,数据来自华山胶质瘤登记,纳入912例成人胶质母细胞瘤患者。
- 术中多模态技术使用不足2种定义为非多模态组,使用2种及以上定义为多模态组。
- 按诊断日期(2010-2014年或2015-2019年)分层比较两组预后。
主要发现
- 胶质母细胞瘤患者中位总生存期为17.70个月,中位无进展生存期为12.03个月。
- 多模态组总生存期为21.0个月,非多模态组为16.0个月(P<0.001)。
- 2015-2019年组总生存期为22.0个月,2010-2014年组为16.0个月(P<0.001)。
- 多模态技术更常用于2015-2019年组的手术中。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: In recent years, numerous neurosurgical multimodal techniques have been utilized to maximize tumor resection safely and effectively. However, the synergetic effects of neurosurgical multimodalities on the survival of glioblastoma patients remain unclear. This study evaluated the role of intraoperative utilization of multimodalities in glioblastoma patients. METHODS: Data of 912 adult patients with glioblastoma were obtained from the Huashan Glioma Registry. The utilization of fewer than 2 (multimodality value < 2) intraoperative multimodal techniques was defined as the nonmultimodal group. In contrast, the utilization of 2 or more (multimodality value ≥ 2) intraoperative multimodal techniques was regarded as the multimodal group. The prognosis of the 2 cohorts was compared and further stratified based on the diagnosis date (2010-2014 or 2015-2019) to reveal the role of the application of multimodal techniques. RESULTS: The median overall survival (OS) and progression-free survival of glioblastoma patients were 17.70 months and 12.03 months, respectively. The OS time of the multimodal group was noticeably longer than that of the nonmultimodal group (21.0 months vs. 16.0 months, P < 0.001). Multimodal techniques were more frequently applied in surgery in the 2015-2019 group than in the 2010-2014 group. The popularity of multimodal techniques contributed to significant improvement in the prognosis of glioblastoma patients from 2010-2014 to 2015-2019 (OS, 16.0 months vs. 22.0 months, P < 0.001). CONCLUSIONS: This study indicated that the utilization of intraoperative multimodal techniques improved the extent of resection and elevated the survival for adult glioblastoma patients.
引用
- Xiong Z, Luo C, Wang P, et al. The Intraoperative Utilization of Multimodalities Could Improve the Prognosis of Adult Glioblastoma: A Single-Center Observational Study. World Neurosurg. 2022. PMID: 35760324. doi:10.1016/j.wneu.2022.06.094
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。